Fifth Third Bancorp
VNRX icon

Fifth Third Bancorp’s VolitionRx Ltd VNRX Stock Holding History

Fifth Third Bancorp’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$23K – 2537
2021
Q1 		$23K Hold
300
– – ﹤0.01% 1732
2020
Q4 		$23K Hold
300
– – ﹤0.01% 1671
2020
Q3 		$19K Hold
300
– – ﹤0.01% 1598
2020
Q2 		$23K Buy
+300
New +$21.7K ﹤0.01% 1514

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's VNRX Position: Q2 2021 in Review

Fifth Third Bancorp sold out of VolitionRx Ltd (VNRX) in Q2 2021, closing a stake of 300 shares — an estimated $23K sold.

Fifth Third Bancorp first reported a position in VNRX in Q2 2020 and held it in 4 quarters. The position peaked at $23K in Q1 2021. 46 funds tracked by Wall St. Rank hold VNRX as of Q2 2021.

  • Fifth Third Bancorp reported no remaining VolitionRx Ltd position as of Q2 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 300 VolitionRx Ltd shares in Q2 2021, an estimated $23K.
  • Fifth Third Bancorp first reported a position in VolitionRx Ltd in Q2 2020 and held it in 4 quarters.
  • Fifth Third Bancorp's VolitionRx Ltd position peaked at $23K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2021.

Based on Fifth Third Bancorp's 13F filing for Q2 2021, filed 6 Aug 2021.